Vape Dojo Corporate Headquarters Warning Letter Details

Summary

Based on limited metadata with no full letter text available, this FDA Warning Letter issued on March 27, 2020, was directed at Vape Dojo Corporate Headquarters regarding tobacco products, likely e-cigarettes or vaping devices. Without a subject line or detailed violation information, the specific regulatory concerns cannot be determined from the metadata alone, though FDA warnings to vaping companies typically address issues such as marketing claims, product testing, or compliance with tobacco regulations. The warning falls under FDA's tobacco product regulatory authority, though the specific issuing office is not identified in the available metadata. A review of the full letter would be necessary to identify the specific violations cited and required corrective actions.